Ventripoint Provides Videoconference Link to Annual General Meeting and Corporate Update

About this update from Ventripoint Diagnostics Ltd.

Ventripoint Provides Videoconference Link to Annual General Meeting and Corporate Update (TheNewswire)   Toronto, Canada – TheNewswire - May 25, 2026 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company") (TSXV:VPT; OTC:VPTDF), a leading provider of innovative AI-powered cardiac diagnostic solutions, is pleased to provide a videoconference link for its Annual General Meeting, which will be followed by a corporate update.   Shareholder Videoconference: Date:                 Wednesday May 27, 2026 Time:                 11:00 am EST   Join Zoom Meeting https://us02web.zoom.us/j/81065498156?pwd=KsfnCdZcLJAtgHxcZy6Mc4YD4asIW2.1   Meeting chat link https://us02web.zoom.us/launch/jc/81065498156   Meeting ID: 810 6549 8156 Passcode: 224522   One tap mobile +17193594580,,81065498156#,,,,*224522# US +12532050468,,81065498156#,,,,*224522# US   Join by SIP • [email protected]   Join instructions   https://us02web.zoom.us/meetings/81065498156/invitations?signature=J08ymXcI8AI1g33uRzqvp4bZ5NA1qnaU1BX7MeLbvYU      About Ventripoint Diagnostics Ltd.   Ventripoint has become an industry leader in the application of AI (Artificial Intelligence) to echocardiography. Ventripoint's VMS+ products are powered by its proprietary knowledge-based reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI. This affordable, gold-standard alternative allows cardiologists greater confidence in the management of their patients. Providing better care to patients serves as a springboard and basic standard for all of Ventripoint's products that guide our future developments. In addition, VMS+ is versatile and can be used with all ultrasound systems from any vendor supported by regulatory market approvals in the U.S., Europe and Canada.   For further information, please contact:   Hugh MacNaught, CEO [email protected] 604-671-4201   Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.   Forward Looking Statements   This news release cont...

View stock analysis, news, and events for Ventripoint Diagnostics Ltd.